All 2017 2016 2015 2014 2013 2010

Clinical data shows pioneering Manchester diagnostic device offers increased detection of cervical cancer

A pioneering diagnostic device identifies more abnormal cells on the cervix than standard colposcopy, according to data published in two European clinical papers. ZedScan is…
Continue reading

Impact of Videregen’s technology recognised as it joins UK’s Social Stock Exchange

New source of capital for company as pipeline develops  Liverpool, UK - June 12 2017:  Videregen Limited, a clinical stage regenerative medicine company developing…
Continue reading

Further Isle Of Man enterprise development scheme deals completed

Press Release - 24th May 2017 Further Isle of Man Enterprise Development Scheme (EDS) investments have continued to complete in the last month,…
Continue reading

Cytox Plans US Clinical Launch for Early-Stage Alzheimer’s Test While Courting Pharma Partners

NEW YORK (GenomeWeb) – British molecular diagnostics company Cytox plans to make a molecular test for the early-stage diagnosis of Alzheimer's disease available…
Continue reading

First Isle of Man Enterprise Development Scheme deals complete

The Isle of Man Enterprise Development Scheme’s first investments are complete. Funding of over £1.2 million is already committed to help bring new…
Continue reading

ISLEXPO 2017

Relocate and grow your business on the Isle of Man. A destination for international business with an excellent quality of life. Find out…
Continue reading

Merger delivers expansion for Manchester-based Diagnostic Healthcare

Medical diagnostic company Diagnostic Healthcare Ltd has merged with ultrasound services provider Excell Ultrasound. Manchester-based Diagnostic said the deal, announced today (March 29),…
Continue reading

Sky Medical Technology and the geko™ device shortlisted for prestigious Healthcare Business Awards

Sky Medical Technology has been shortlisted for the Medilink North West Healthcare Business Awards 2017 in the category of ‘Partnership with the NHS’.…
Continue reading

UK cervical cancer diagnostic system to be piloted in India as part of TechEmerge’s programme

Zilico Ltd – a developer of a pioneering cervical cancer diagnostic system - has been selected by the IFC, a member of the…
Continue reading

Cytox presentations on studies with breakthrough genetic biomarker research assay for Alzheimer’s disease risk assessment at CTAD 2016

Novel SNP profiling approach for AD risk stratification to be highlighted in San Diego 1st December 2016, Oxford, UK. Cytox Ltd, an innovative…
Continue reading

Bionow Award Winners!

November 28, 2016 Perfectus Biomed are delighted to formally announce that the company has been awarded the “Technical Service Award” by Bionow at…
Continue reading

Progress in Videregen’s patent portfolio on biological scaffolds for replacement organs

Applications on novel production methods granted in UK & accepted in Australia Liverpool, UK - November 7 2016: Videregen Limited, a clinical stage…
Continue reading

LumbaCurve Back Pain Relief Device Scoops Innovation Award

Back Pain Relief Device Scoops Innovation Award UK company LumbaCurve International picks up Product of The Year Award at Olympia for its revolutionary…
Continue reading

Videregen’s lead product granted EU orphan drug status

Recognition of potential of personalised trachea replacement in airways disease Liverpool, UK - October 3 2016: Videregen Limited, a clinical stage regenerative medicine company…
Continue reading

Sky Medical Technology Recognised As a Growth Champion

Sky Medical Technology has been shortlisted for Growth Champion of the Year for the 2016 Growth Investor Awards, which recognise impact beyond investment…
Continue reading

Cytox early test for Alzheimer’s offers hope to millions – ‘The Times’ front page news

Published in 'The Times'  Friday 22nd July 2016 Written by Oliver Moody -  Science Correspondent People who develop mild memory problems in middle age will…
Continue reading

Funding speeds up growth at Diagnostic Healthcare

Following its funding from The North West Fund back in 2013, the business has seen its turnover rise by 400 per cent. [caption…
Continue reading

£150,000 boost for drug development firm Incanthera

Incanthera is committed to the development of pioneering technologies that target solid tumours. The team at Manchester-based Incanthera A…
Continue reading

IFB2016 Funding Businesses at Every Stage – Launching the Isle of Man £50 million Enterprise Development Scheme

Date of Event: 24 June 2016 Time of events: 10:00 to 12:00 12.00 to 14:00 Location: Exhibition Centre Liverpool, Kings Dock, Liverpool Waterfront, L3 Followed…
Continue reading

SwabTech in funding round

A Manchester-based business which aims to recover a patient’s own blood from swabs during surgery is seeking to raise almost £600,000 via crowdfunding platform SyndicateRoom.…
Continue reading

Liverpool cancer drug research firm Evgen Pharma now running two trials

Firm's strong funding position supporting progress on clinical trials Liverpool cancer drug research specialist Evgen Pharma says it has made significant progress on trials…
Continue reading

ZedScan™ delivers significant increase in HG CIN detection rates across all high risk HPV positive women

A review into the management of more than 800 women referred to an NHS colposcopy clinic who were positive for high risk HPV…
Continue reading

LumbaCurve Back Pain Relief a Winner in Germany

Liverpool Science Park based LumbaCurve International have won their first substantial export order from Germany it’s revolutionary back pain relief device, previously showcased…
Continue reading

SPARK Impact appointed manager of Isle of Man £50million Enterprise Development Scheme

We are delighted to announce that SPARK Impact has been appointed manager of the £50 million Enterprise Development Scheme (EDS) by the Isle…
Continue reading

Incanthera to receive grant from Yorkshire Cancer Research

Incanthera, (the Company) is pleased to announce that Yorkshire Cancer Research has awarded the Company a grant towards the funding of the Phase…
Continue reading

ZedScan featured in ‘The Pathologist‏’

ZedScan™ is the focus of an extensive feature in the latest edition of The Pathologist magazine. The article - Conquering the Challenges of Colposcopy - written…
Continue reading

1,000 patient case study published for ZedScan™

Zilico Ltd has published a 1,000 patient case study for its cervical cancer diagnostic system, ZedScan™. The patient review in to the routine…
Continue reading

Zilico appoints new Commercial Director

Medilink North West member Zilico Ltd has strengthened its team with the appointment of a new Commercial Director. Andrew Saipe, who has 25…
Continue reading

New CEO for Artificial Intelligence drug discovery business Molplex‏

The highly innovative and world leading Artificial Intelligence drug discovery business Molplex, (based at BioCity, BioHub, Alderley Park), has appointed Victoria Camargo as…
Continue reading

QVC go for LumbaCurve Back Pain Relief

Press Release 22 Dec 2015 LumbaCurve has been successful in landing its first order from the multinational TV shopping channel QVC. The revolutionary…
Continue reading

Videregen/TETRA awarded €6.8m by Horizon 2020 for trachea trial

Horizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trial EU study to build on Phase I trial of Videregen product &…
Continue reading

Sky Medical Technology Wins the BioNow Investment Deal of the Year Award

In 2015 Sky Medical Technology completed a £3m equity investment from a Japanese >$1bn Multinational with operational capabilities in strategically significant markets for…
Continue reading

Central Manchester University Hospitals NHS Foundation Trust (CMFT) adopts ZedScan

Central Manchester University Hospitals NHS Foundation Trust (CMFT) has introduced ZedScan™ into its cervical cancer care pathway. The system will be utilised at…
Continue reading

The North West Fund hits £50m milestone in Merseyside

£50m invested into the Liverpool City Region... The North West Fund has surpassed the £50m investment mark, funding over 145 businesses across the…
Continue reading

Enterprise Europe Network – Horizon 2020 brokerage event

REGISTER AND FIND THE RIGHT PARTNERS FOR H2020 2016-2017 CALLS! The platform is now open! Click here to register Get involved in the…
Continue reading

£250,000 for Absynth Biologics

Absynth Biologics received the cash from Alderley Park Ventures, the £5m investment fund created in late 2014 and managed by BioCity, to invest…
Continue reading

The 14th Bionow Annual Awards successfully showcases the best of the northern life sciences sector

  Bionow, is delighted to announce the winners of the 2015 Bionow Annual Awards, the ceremony for which took place at the Mere…
Continue reading

University of Liverpool SME Voucher Scheme

The Voucher Scheme is a way to develop links between the University and the Business Community. Regional Businesses (North of England) can apply…
Continue reading

Evgen Pharma PLC Expands Pipeline with Novel Compounds

Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has acquired exclusive worldwide…
Continue reading

Four Spark Impact companies shortlisted for the BioNow Awards November 2015

Bionow is delighted to announce the shortlisted nominees for the 2015 Bionow Annual Awards, which will take place at the Mere Golf Resort…
Continue reading

Recognition for Cytox consultant John Hardy

British researcher John Hardy among those to win a Breakthrough prize at ceremony hosted by Seth MacFarlane in the US [caption id="attachment_1918" align="aligncenter"…
Continue reading

Secret Saviours features in Hello magazine

Continue reading

ZedScan to be presented at MEDICA 2015‏

Zilico at MEDICA MEDICA will take place between the 16 – 19 November 2015 at the Messe Düsseldorf, Germany. Zilico Ltd will be…
Continue reading

Gelexir named in top 49 startups

Based: Manchester Founded: 2012 What do you do: The University of Manchester spin-out has developed a hydrogel to relieve back pain by allowing…
Continue reading

Clinical trial for replacement trachea technology to start next year

INSPIRE consortium receives UK MHRA approval for study Liverpool and London, UK - November 3 2015: The INSPIRE consortium, led by Videregen Ltd,…
Continue reading

Evgen Pharma plc – shares commence trading

SPARK Impact Ltd is pleased to announce that Evgen Pharma plc, a portfolio company of the North West Fund for Biomedical, has been…
Continue reading

New Chairman appointed for Bioxydyn

Wilmington, DE, 13th October 2015 – The Pistoia Alliance has appointed Dr Steve Arlington as its new President. Steve joins as the Pistoia…
Continue reading

The geko® and firefly® devices win prestigious Japan Good Design Award 2015

Sky Medical Technology Ltd is proud to announce that the geko® and firefly® devices have won the prestigious Japan Good Design Award. The…
Continue reading

Cytox announces participation in INSIGHT Alzheimer’s study

Cytox announces participation in INSIGHT Alzheimer’s study Participation will aid comparison of SNP genotyping with biomarker status   12th October 2015: Oxford, UK. Cytox…
Continue reading

Sky Medical Technology and the geko® device shortlisted for two prestigious Innovate UK awards

Sky Medical Technology, the developer and manufacturer of the geko® device, has been shortlisted in two categories - Innovation Leading to New Markets…
Continue reading

Broccoli powers UK pharma group to float

A Liverpool-based company aiming to harness the power of broccoli to fight cancer and strokes has joined the procession of drug developers planning…
Continue reading

Kanichi Research Services successfully secures grant funding

Kanichi Research Services Ltd would like to announce the Company has been successful in securing grant funding on the Horizon 2020 Small and…
Continue reading

Spark portfolio companies among BioCap Conference Pitching Competition Winners

We are delighted a number of SPARK Impact portfolio companies have been named as successful applicants for the 'Call for Company Pitches' competition,…
Continue reading

SPARK Impact makes joint investment with Alderley Park Ventures

Alderley Park Ventures, the investment fund created in late 2014 and managed by BioCity, has announced its first investment - a £200,000 equity…
Continue reading

Supporting integrated business and health communities

The Innovation Nexus is an invaluable resource for SMEs doing business with the NHS in Greater Manchester. Launching a new product is a…
Continue reading

Northern Powerhouse market visit to Beijing (Bio-Medical Focus)

  UKTI and RTC North are organising a Northern Powerhouse trade and investment mission to China for organisations serving the health sector across…
Continue reading

Absynth appears in industry report

Our investee company Absynth Biologics is one of the companies featured in a new report published by the UK BioIndustry Association (BIA). Published following the announcement…
Continue reading

Boost for innovative North West healthcare technologies

A North West life sciences investor has ploughed a further £1.6m into companies developing cutting edge healthcare technologies including those for combatting and…
Continue reading

Cytox and Affymetrix form strategic partnership

Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research…
Continue reading

Dr Andy Round gives opinion on NHS devolution to Greater Manchester Business Week

Devolving healthcare spending to councils in Greater Manchester has been dubbed the most ground-breaking change to happen to the NHS since its creation…
Continue reading

£400,000 Follow on Investment for Stem Cell Innovator

  Spin-out regenerative medicine company, Videregen, has received £400,000 in follow on funding from The North West Fund for Biomedical, managed by SPARK…
Continue reading

Gelexir receives investment from SPARK Impact

A University of Manchester spin-out which has developed a hydrogel to relieve back pain has received funding from The North West Fund for Biomedical…
Continue reading

Cytox signs research agreement with AIBL and partner organisations

  Collaboration will contribute to further refinement of diagnostic SNPs for Alzheimer’s disease. Cytox Ltd, an innovative developer of assays for risk assessment…
Continue reading

Enterprise Europe Network gives presentation to SPARK companies

The Enterprise Europe Network  (EEN), will be visiting Liverpool Science Park on Monday 29th June to give a 90 minute presentation to SPARK investee…
Continue reading

Dr Andy Round talks about Funding for Translation

Andy Round, investment director at SPARK Impact took part in the University of Liverpool and Bionow Research and Innovation event yesterday. The full…
Continue reading

Dr Andy Round to take part in Insider: Future of the North debate

  Andy Round, investment director at SPARK Impact is set to take part in North West Insider’s ‘Future of the North – The…
Continue reading

BSCCP presentation drives demand for ZedScan™ throughout the UK

  Interest in ZedScan is expanding significantly throughout the UK following Dr Madeleine MacDonald’s presentation at the 2015 British Society for Colposcopy and…
Continue reading

New Devo Manc deal will help drive new innovations to the NHS

That was the view of the panel at today’s pro-manchester Healthcare Sector Group event ‘Innovations in Healthcare’. Held at Citylabs 1.0, a £25m…
Continue reading

SPARK Impact boosts North West Companies with £1.1m Follow on Funding

  Life sciences investor SPARK Impact has continued to boost the North West’s biomedical sector by providing follow on funding into healthcare companies…
Continue reading

SPARK joins healthcare innovation debate

  Our investment director Dr Andy Round will be sparking some healthy debate at a breakfast event in Manchester on Tuesday, May 5th.…
Continue reading

Synthetic version of broccoli compound is potential treatment for osteoarthritis

A synthetic and stable form of a chemical found in broccoli could be used as a potential treatment for osteoarthritis after positive results from…
Continue reading

New Drug Combination from Liverpool Company Shows Promise for Breaking Breast Cancer Resistance

Liverpool based drug development company, Evgen Pharma, working with researchers from The University of Manchester, have developed a new combination of drugs which…
Continue reading

LumbaCurve featured in The Bone and Joint Journal

An abstract of Spark Impact investee company LumbaCurve, has featured in leading trade magazine The Bone and Joint Journal. The article outlines the clinical…
Continue reading

Cytox awarded Innovate UK funding for stratification of neurodegenerative diseases

  Funding will aid clinical evaluation of genetic panel in MCI risk stratification, says CEO Cytox an innovative developer of assays for risk…
Continue reading

Election 2015: Spark Impact give their opinions

Each week, online business publication Bdaily ask businesses from a different area of the North West for their opinions and hopes from the upcoming…
Continue reading

Save the Date: Research & Innovation Showcase

Andy Round is set to speak at the Research & Innovation Showcase on the 20th May, 2015. See below a save the date.  
Continue reading

Recommended event: Infection Catalyst Event

Wednesday 29th April 2015, 9.30am - 4.30pm  The Liner Hotel, Liverpool  The North West Coast Academic Health Science Network (NWC AHSN) and the…
Continue reading

Manchester Science Partnerships launch video to show Manchester as the European City of Science

Manchester Science Partnerships and Marketing Manchester launched an impressive video at last month’s MIPIM festival showcasing Manchester's past achievements in science and innovation.…
Continue reading

NHS organisation is looking for innovative technologies to evaluate

  NHS Oldham Clinical Commissioning Group (CCG) is searching for companies who are developing innovative technologies designed to improve patient care and patient…
Continue reading

Latest Spark newsletter is out now

Interested in what Spark Impact have been up to over the past few months and to read the latest news from some of…
Continue reading

SPARK Impact opens office at the BioHub

SPARK Impact has expanded in the North West region with the launch of a second office at BioHub at Alderley Park, Cheshire. The…
Continue reading

North West needs continued investment in life sciences, says Andy Round

With a £42m life-sciences investment fund set to be launched this year and pledges from Prime Minister David Cameron and Chancellor George Osborne…
Continue reading

Mills & Reeve advises North West Fund for Biomedical on investments worth £7m

Leading national law firm Mills & Reeve acted for SPARK Impact Limited, as fund manager for the North West Fund for Biomedical, on…
Continue reading

SPARK Investee Company features on the Daily Mail Online

A SPARK Impact investee company which has developed an innovative solution to reduce stretch marks in pregnant women has officially launched its product…
Continue reading

SPARK Impact reaches milestone deal

SPARK Impact has made its 101st transaction into healthcare companies across the North West. Since the start of December, SPARK Impact, manager of…
Continue reading

Successful Fundraising Acquisition of New Drug Progamme Acquisition of Spear Therapeutics Limited

Incanthera (“the Company”), is pleased to announce a successful fundraising of £1.3 million from existing and new investors; acquisition of a new drug…
Continue reading

SPARK Impact features in life-science supplement in The Times

SPARK Impact, managers of the £30 million North West Fund for Biomedical have featured in the life-science supplement in The Times published on…
Continue reading

SPARK Impact investee company to collaborate with AstraZeneca

One of SPARK Impact’s investee companies has announced a pioneering new research collaboration agreement with AstraZeneca. Molplex Pharmaceuticals is a drug discovery company…
Continue reading

Clinical trial success for Spark Impact back pain relief product

  Liverpool based LumbaCurve International, backed by SPARK Impact, manager of The North West Fund for Biomedical, have announced that clinical trials of…
Continue reading

Supporting companies to do business with the NHS

Companies, especially SMEs, can face significant challenges trying to introduce their new and innovative products into the NHS. The complexity of public procurement,…
Continue reading

Zilico named in report on growth of cervical cancer diagnostics market‏

Zilico Ltd has been profiled as a key participant in a recent independent report on the Cervical Cancer Diagnostics market, alongside major players…
Continue reading

SPARK Impact investee company wins Medilink North West Award 2014.

  SPARK Impact is delighted to announce that investee company Perfectus Biomed has been honoured at the Medilink North West Awards 2014, which…
Continue reading

Health is wealth strategic conference

Continue reading

Double success for SPARK Impact at Bionow awards

Two companies from The North West Fund for Biomedical portfolio, managed by SPARK Impact, were among the winners of this year’s prestigious Bionow…
Continue reading

SPARK Impact investee companies shortlisted for Bionow 2014 awards

SPARK Impact is delighted to announce that eight investee companies, from ‘The North West Fund for Biomedical’ portfolio have been shortlisted for the…
Continue reading

Kanichi scoops innovation award

Manchester-based Kanichi Research has won an innovation competition that could see it revolutionise the diagnosis of diseases through a unique hand-held device which…
Continue reading

SPARK Impact receives £5m boost to invest in more North West biomedical businesses

The North West Fund for Biomedical, managed by SPARK Impact, has received a £5m top up taking its fund allocation to £30m. Since…
Continue reading

Molplex Brief

Molplex invents new medicines using artificial intelligence (A.I.) and a robotic laboratory. Our A.I. systems are faster and more effective than scientists at…
Continue reading

Life-saving stem cell technology receives funding

A developer of stem cell organ regenerative medicine which was built on the foundations of a ground breaking operation which saved a ten…
Continue reading

Bioxydyn are transforming lung MRI at ERS 2014

Catch their breath Regional, Dynamic Estimation of Lung Oxygen Delivery using Conventional MRI A simple, repeatable, cost-effective free-breathing imaging protocol typically lasting just…
Continue reading

Medical supplier of women’s healthcare products secures significant investment for growth

A specialist women’s healthcare start-up has secured a combined investment of £210,000 which will go towards driving its business growth in the rapidly…
Continue reading

Anti-stretch mark technology receives £400,500 funding

A business which has developed a revolutionary product to help prevent stretch marks during pregnancy has received £400,500 in equity funding from The North…
Continue reading

Investment in Biomedical SMEs in Merseyside hits milestone

Merseyside companies have received a collective £8.6m in funding since the launch of The North West Fund for Biomedical, managed by SPARK Impact,…
Continue reading

Funding Healthcare Innovations

Recommended breakfast event on November 26th Here at SPARK Impact, we thought you might be interested in this Liverpool Science Park event featuring a speaker from…
Continue reading

Spinout Company secures £850,000 to develop vaccines against infection

A COMPANY working to develop vaccines and antibodies to treat bacterial infections has secured a £850,000 investment. Absynth Biologics Limited, a UK biotechnology…
Continue reading

North West Digital Clinical Trial Recruitment Company Secures Six Figure Investment

A UK COMPANY which offers an innovative solution to recruit and retain global participants for medicine clinical trials has secured an investment of…
Continue reading

£100,000 investment for microbiology company

A COMPANY which offers bespoke microbiological testing has secured £100,000 investment. Perfectus Biomed, based at Sci-Tech Daresbury, received £50,000 from The North West…
Continue reading

Neuroradiology Technology Developer Secures £600,000 Investment from The North West Fund for Biomedical

A company which has developed an implantable medical device for treating intracranial aneurysms has secured a £600,000 investment from The North West Fund…
Continue reading

Artificial Fertility Specialist secures £65,000 investment from The North West Fund for Biomedical

An emerging artificial fertility specialist company, whose work could reduce the number of animals used in research by 24 per cent, has secured…
Continue reading

Diagnostic imaging innovator secures £1 million investment from The North West Fund for Biomedical

A LEADING diagnostic imaging company, Diagnostic Healthcare Ltd, has secured £1million investment from The North West Fund for Biomedical, managed by SPARK Impact.…
Continue reading

Infection control innovator secures investment from The North West Fund for Biomedical

The developer of a unique disposable tourniquet, ASep Healthcare, has secured £120,000 investment from The North West Fund for Biomedical, managed by SPARK…
Continue reading

Re-energised Cytox aims to grab Alzheimer’s biomarker market with £3.5 million investment, new, experienced management and a major validation milestone

PRESS RELEASE embargoed to January 25, 2013 at 00.01 hours Manchester & Oxford, UK, 25 January 2013 – Cytox Limited, developer of a…
Continue reading

The North West Fund for Biomedical passes £10m

The North West Fund for Biomedical, managed by SPARK Impact, has now invested more than £10million in SMEs across a range of biomedical…
Continue reading

Back pain relief innovators secure investment from The North West Fund for Biomedical

The North West Fund for Biomedical, managed by SPARK Impact, has invested £125,000 in medical devices company LumbaCurve International Ltd. LumbaCurve International Ltd,…
Continue reading